Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KARL STORZ VentureONE is a wholly owned subsidiary of KARL STORZ focused on building robotic and digital solutions for surgery. Established in 2022 and publicly launched in February 2023, the company is developing an integrated robotic surgery ecosystem that combines surgical robotics with artificial intelligence, virtual reality, imaging, and operating-room workflow technologies. The business is positioned within medtech rather than therapeutics, aiming to support next-generation surgeons and minimally invasive procedures. VentureONE operates from Singapore with an additional engineering and clinical applications presence in the Munich area. It also works with strategic partners to accelerate development and commercialization of robotic and AI-enabled surgical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KARL STORZ VentureONE.